BSECompany Update9 Oct 2026 · 9 Oct 2026, 11:40 am
Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta
Sandu Pharmaceuticals Ltd · 524703
✦ AI SummaryMgmt Change
Sandu Pharmaceuticals Ltd has informed the exchange about a change in the name of its non-executive independent director, Dr. Neeti Madan Kapre, to Dr. Neeti Gupta, due to her marriage, with no change in designation, directorship, or DIN.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sandu Pharmaceuticals Ltd - 524703 - Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
Attachments (1)
📄pdf
Download →
b362342e-920b-4715-b4ba-5a7ac86cd540.pdf
View document text
-::' SANDU PHARMACEUTICALS LIMITED
SANDU
CIN:L24233GA1985PLC001587
W Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
Ref: Corp.Sec/2026-27/BSE/498
Dated:09.10.2026
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai-400001
SCRIPTCODE:524703
Dear Sir/Ma’am,
Sub: Intimation regarding change in name of Director from Dr Neeti Madan Kapre to Dr
Neeti Gupta.
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the name of Dr Neeti Madan Kapre (DIN:
06801264, [Non Executive Independent Director] of the Company, has been changed from
Dr Neeti Madan Kapre to Dr Neeti Gupta consequent upon her marriage.
The change in name has been duly supported by the relevant documentary evidence and
the same has been taken on record by the Company. We further confirm that there is no
change in the designation, directorship or DIN of the Director, and the aforesaid intimation
is only in respect of the change in her name.
This is for your information and appropriate dissemination.
Thanking you,
Yours faithfully,
For. Sandu Pharmaceuticals Limited
Pratika Mhambray
Company Secretary and Compliance Officer
A36512
AN 1SO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in
%u % __ SANDU PHARMACEUTICALS LIMITED
(CIN:L24233GA1985PLC001587
SAMDU
m Regd. Office: Plot Nos. 25, 26, 29 & 30, Pilerne Industrial Estate, Marra, Saligao, Bardez, Goa 403511.
Tel: +91 832 2407474 / 6715000, E-mail: sandupharma@sandu.in, Website: www.sandu.in
ANNEXURE A
Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015.
Sr Particulars Details
1 Name of the Director/ Key | Dr Neeti Gupta (DIN:06801264)
Managerial Personnel
2 Reason for change Change of Name from Dr Neeti Madan Kapre
(DIN:06801264) to Dr Neeti Gupta
3 Date of appointment | NA
/Cessation & term of
appointment
4 Brief Profile NA
5 Disclosure of | NA
relationships between
directors (in case of
appointment of a director)
6 Information as required | NA
Circular No. LIST/COMP/
14/2018- 19 and
NSE/CML/2018/24
For. Sandu Pharmaceuticals Limited
Pratika Mhambray
Company Secretary and Compliance Officer
A 36512
AN 1SO 9001:2015 CERTIFIED ORGANISATION
Corporate Office: P. B. No. 17201, Sandu Nagar, D. K. Sandu Marg, Chembur, Mumbai — 400 071
Tel.: +91 22 2528 4402 / 3306, E-mail: info@sandu.in